Furlanut M - Search Results

1

Adjuvant treatment with cyclosporin A increases the toxicity of chemotherapy for remission induction in acute non-lymphocytic leukemia.

Damiani D, Michieli M, Ermacora A, Russo D, Fanin R, Zaja F, Baraldo M, Pea F, Furlanut M, Baccarani M. Damiani D, et al. Among authors: furlanut m. Leukemia. 1998 Aug;12(8):1236-40. doi: 10.1038/sj.leu.2401092. Leukemia. 1998. PMID: 9697878 Clinical Trial.

2

Blood concentrations and clinical effect of cyclosporin in psoriasis.

Furlanut M, Baraldo M, Pea F, Marzocchi V, Croattino L, Galla F. Furlanut M, et al. Ther Drug Monit. 1996 Oct;18(5):544-8. doi: 10.1097/00007691-199610000-00004. Ther Drug Monit. 1996. PMID: 8885117 Clinical Trial.

3

Multidrug resistance modulation in vivo: the effect of cyclosporin A alone or with dexverapamil on idarubicin pharmacokinetics in acute leukemia.

Pea F, Damiani D, Michieli M, Ermacora A, Baraldo M, Russo D, Fanin R, Baccarani M, Furlanut M. Pea F, et al. Among authors: furlanut m. Eur J Clin Pharmacol. 1999 Jul;55(5):361-8. doi: 10.1007/s002280050641. Eur J Clin Pharmacol. 1999. PMID: 10456485

4

Liposomal daunorubicin plasmatic and renal disposition in patients with acute leukemia.

Pea F, Russo D, Michieli M, Baraldo M, Ermacora A, Damiani D, Baccarani M, Furlanut M. Pea F, et al. Among authors: furlanut m. Cancer Chemother Pharmacol. 2000;46(4):279-86. doi: 10.1007/s002800000163. Cancer Chemother Pharmacol. 2000. PMID: 11052625

5

Chronopharmacokinetics of ciclosporin and tacrolimus.

Baraldo M, Furlanut M. Baraldo M, et al. Among authors: furlanut m. Clin Pharmacokinet. 2006;45(8):775-88. doi: 10.2165/00003088-200645080-00002. Clin Pharmacokinet. 2006. PMID: 16884317 Review.

6

Disposition of liposomal daunorubicin during cotreatment with cytarabine in patients with leukaemia.

Pea F, Russo D, Michieli M, Damiani D, Fanin R, Michelutti A, Michelutti T, Piccolrovazzi S, Baccarani M, Furlanut M. Pea F, et al. Among authors: furlanut m. Clin Pharmacokinet. 2003;42(9):851-62. doi: 10.2165/00003088-200342090-00004. Clin Pharmacokinet. 2003. PMID: 12882589

7

Teicoplanin in patients with acute leukaemia and febrile neutropenia: a special population benefiting from higher dosages.

Pea F, Viale P, Candoni A, Pavan F, Pagani L, Damiani D, Casini M, Furlanut M. Pea F, et al. Among authors: furlanut m. Clin Pharmacokinet. 2004;43(6):405-15. doi: 10.2165/00003088-200443060-00004. Clin Pharmacokinet. 2004. PMID: 15086277 Clinical Trial.

8

Ceftazidime in acute myeloid leukemia patients with febrile neutropenia: helpfulness of continuous intravenous infusion in maximizing pharmacodynamic exposure.

Pea F, Viale P, Damiani D, Pavan F, Cristini F, Fanin R, Furlanut M. Pea F, et al. Among authors: furlanut m. Antimicrob Agents Chemother. 2005 Aug;49(8):3550-3. doi: 10.1128/AAC.49.8.3550-3553.2005. Antimicrob Agents Chemother. 2005. PMID: 16048982 Free PMC article.

9

Effect of fluctuations of blood cyclosporine concentrations on renal function.

Furlanut M, Baraldo M, Pea F, Albanese MC, Albertini A, Puricelli C. Furlanut M, et al. Transplant Proc. 1994 Oct;26(5):2574-5. Transplant Proc. 1994. PMID: 7940796 No abstract available.

10

Effects of different sampling strategies on predictions of blood cyclosporine concentrations in haematological patients with multidrug resistance by Bayesian and non-linear least squares methods.

Wu G, Baraldo M, Pea F, Cossettini P, Furlanut M. Wu G, et al. Among authors: furlanut m. Pharmacol Res. 1995 Dec;32(6):355-62. doi: 10.1016/s1043-6618(05)80040-4. Pharmacol Res. 1995. PMID: 8736486

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

137 results

Search Page

Filters